173 related articles for article (PubMed ID: 30425939)
1. Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients.
Prasad KT; Kaur H; Muthu V; Aggarwal AN; Behera D; Singh N
World J Clin Oncol; 2018 Nov; 9(7):140-147. PubMed ID: 30425939
[TBL] [Abstract][Full Text] [Related]
2. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.
Buccheri G; Ferrigno D; Tamburini M
Eur J Cancer; 1996 Jun; 32A(7):1135-41. PubMed ID: 8758243
[TBL] [Abstract][Full Text] [Related]
3. The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.
Paiva CE; Siquelli FA; Santos HA; Costa MM; Massaro DR; Lacerda DC; Nunes JS; de Pádua Souza C; Paiva BS
BMC Cancer; 2015 Jul; 15():501. PubMed ID: 26142726
[TBL] [Abstract][Full Text] [Related]
4. Simple prognostic model for patients with advanced cancer based on performance status.
Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
[TBL] [Abstract][Full Text] [Related]
5. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools.
de Kock I; Mirhosseini M; Lau F; Thai V; Downing M; Quan H; Lesperance M; Yang J
J Palliat Care; 2013; 29(3):163-9. PubMed ID: 24380215
[TBL] [Abstract][Full Text] [Related]
6. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.
Zimmermann C; Burman D; Bandukwala S; Seccareccia D; Kaya E; Bryson J; Rodin G; Lo C
Support Care Cancer; 2010 May; 18(5):609-16. PubMed ID: 19629537
[TBL] [Abstract][Full Text] [Related]
7. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
[TBL] [Abstract][Full Text] [Related]
8. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals.
Azam F; Latif MF; Farooq A; Tirmazy SH; AlShahrani S; Bashir S; Bukhari N
Case Rep Oncol; 2019; 12(3):728-736. PubMed ID: 31616281
[TBL] [Abstract][Full Text] [Related]
9. Inter-rater reliability in performance status assessment among health care professionals: a systematic review.
Chow R; Chiu N; Bruera E; Krishnan M; Chiu L; Lam H; DeAngelis C; Pulenzas N; Vuong S; Chow E
Ann Palliat Med; 2016 Apr; 5(2):83-92. PubMed ID: 27121736
[TBL] [Abstract][Full Text] [Related]
10. Performance status and survival in cancer patients undergoing palliative care: retrospective study.
Allende-Pérez S; Rodríguez-Mayoral O; Peña-Nieves A; Bruera E
BMJ Support Palliat Care; 2022 Aug; ():. PubMed ID: 35948390
[TBL] [Abstract][Full Text] [Related]
11. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
[TBL] [Abstract][Full Text] [Related]
12. The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales.
de Borja MT; Chow E; Bovett G; Davis L; Gillies C
Support Cancer Ther; 2004 Oct; 2(1):59-63. PubMed ID: 18628160
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Evaluation of Neurological Assessment of the Neuro-Oncology Scale in Glioblastoma Patients.
Lee J; Park SH; Kim YZ
Brain Tumor Res Treat; 2018 Apr; 6(1):22-30. PubMed ID: 29644808
[TBL] [Abstract][Full Text] [Related]
14. Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.
Jiménez Galán R; Prado-Mel E; Pérez-Moreno MA; Caballano-Infantes E; Flores Moreno S
Biology (Basel); 2021 Sep; 10(9):. PubMed ID: 34571767
[TBL] [Abstract][Full Text] [Related]
15. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
Schnadig ID; Fromme EK; Loprinzi CL; Sloan JA; Mori M; Li H; Beer TM
Cancer; 2008 Oct; 113(8):2205-14. PubMed ID: 18780322
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
17. Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists.
Kim YJ; Hui D; Zhang Y; Park JC; Chisholm G; Williams J; Bruera E
J Pain Symptom Manage; 2015 Jun; 49(6):1050-1058.e2. PubMed ID: 25542550
[TBL] [Abstract][Full Text] [Related]
18. Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
Collins JT; Noble S; Davies HE; Farewell D; Lester JF; Parry D; Byrne A
Eur J Cancer Care (Engl); 2019 May; 28(3):e13004. PubMed ID: 30761639
[TBL] [Abstract][Full Text] [Related]
19. Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis.
Chow R; Bruera E; Temel JS; Krishnan M; Im J; Lock M
Support Care Cancer; 2020 May; 28(5):2071-2078. PubMed ID: 31900613
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.
Song T; Wan Q; Yu W; Li J; Lu S; Xie C; Wang H; Fang M
Oncotarget; 2017 Nov; 8(58):98974-98984. PubMed ID: 29228742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
